Table 2.
Hemoglobin (g/dL) | 13.8 ± 1.2 |
Albumin (g/dL) | 4.2 ± 0.3 |
Triglyceride (mg/dL) | 136 ± 82 |
alkaline phosphatase (IU/L) | 223 ± 59 |
Blood urea nitrogen (mg/dL) | 15 ± 3 |
Creatinine (mg/dL) | 0.74 ± 0.24 |
ucOC (ng/ml) | 3.7 ± 2.5 |
OC (ng/ml) | 7.5 ± 2.7 |
ucOC/OC ratio | 0.46 ± 0.18 |
PIVKA2 (mAU/mL) | 19 ± 7 |
intact parathyroid horomone (pg/mL) | 38.9 ± 22.0 |
Bone specific alkaline phosphatase (μg/l) | 13.8 ± 6.5 |
NTX (nmol BCE/L) | 16.9 ± 5.1 |
high sensitive C-reactive protein (mg/L) | 929 ± 1132 |
Osteoprotegerin (ng/mL) | 91.7 ± 30.8 |
oxidized low density lipoprotein (μg/dL) | 104.9 ± 11.9 |
t-ucMGP (nmol/L) | 2907 ± 1333 |
PK (ng/mL) | 1.94 ± 1.38 |
MK-7 (ng/mL) | 14.2 ± 11.9 |
MK-4 (ng/mL) | 0.4 ± 2.0 |
ucOC uncarboxylated osteocalcin
OC osteocalcin
PIVKA2 protein induced by vitamin K absence or antagonist- 2
NTX collagen type 1 cross-linked N-telopeptide
t-ucMGP total circulating uncarboxylated matrix gla protein
PK philloquinone, MK menaquinone